Beta Drugs Limited (NSE:BETA)
India · Delayed Price · Currency is INR 1,623.10
-48.30 (-2.89%)
Last updated: Dec 5, 2025, 3:12 PM IST
Beta Drugs Market Cap
Beta Drugs has a market cap or net worth of 16.87 billion as of December 5, 2025. Its market cap has decreased by -14.26% in one year.
Market Cap
16.87B
Enterprise Value
17.10B
Revenue
3.86B
Ranking
n/a
PE Ratio
31.16
Stock Price
1,623.10
Market Cap Chart
Since October 25, 2017, Beta Drugs's market cap has increased from 915.98M to 16.87B, an increase of 1,741.96%. That is a compound annual growth rate of 43.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 16.87B | -12.64% |
| Dec 31, 2024 | 19.31B | 36.67% |
| Dec 29, 2023 | 14.13B | 107.04% |
| Dec 30, 2022 | 6.83B | 10.89% |
| Dec 31, 2021 | 6.16B | 497.76% |
| Dec 31, 2020 | 1.03B | 56.85% |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 25, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.32T |
| Divi's Laboratories | 1.70T |
| Cipla | 1.23T |
| Apollo Hospitals Enterprise | 1.05T |
| Zydus Lifesciences | 948.58B |
| Mankind Pharma | 920.37B |
| Aurobindo Pharma | 706.37B |
| Fortis Healthcare | 691.35B |